Evaluation of the Effectiveness of Focused Radiofrequency (TECAR) Therapy on Pain, Disability, Function, and Quality of Life in Patients With Lumbar Disc Herniation
NCT ID: NCT07335718
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
54 participants
OBSERVATIONAL
2025-01-01
2026-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Radiofrequency Nucleoplasty and Targeted Disc Decompression in Lumbar Radiculopathy
NCT02025283
Percutaneous Intradiscal Radiofrequency as A Treatment for Radicular Pain From Lumbar Disc Herniation
NCT05747807
Effect of Pulsed Mode Radiofrequency as a Treatment of Lumbar Disc Related Radicular Pain on Tumor Necrotic Factor α Level
NCT05288920
High Power Laser Therapy for Herniated Disc and Lumbosacral Radiculopathy
NCT06831227
Relief of Lumbar Spinal Stenosis Symptoms
NCT06393959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
According to the study criteria, initial evaluations will be performed by a single Physical Medicine and Rehabilitation physician. Demographic data of eligible patients, including age, sex, height, weight, occupation, and systemic diseases, will be recorded.
Patients will be evaluated before treatment, immediately after treatment, and one month after the end of treatment using the following scales: Visual Analog Scale (VAS) for pain, Numeric Rating Scale (NRS), Quality of Life Scale (SF-36), Roland-Morris Disability Questionnaire, Oswestry Disability Index, Finger-to-Floor Distance Measurement, Beck Depression Inventory, and Lumbar Schober Test.
Patients will be divided into two groups. The first group will receive a home exercise program including lumbar active range of motion exercises and lumbar isometric strengthening exercises, performed five times per week for three weeks according to the level of movement restriction and pain severity, along with TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions.
The second group will receive the same home exercise program-including lumbar active range of motion exercises and lumbar isometric strengthening exercises-performed five times per week for three weeks according to the level of movement restriction and pain severity, along with sham TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TECAR Therapy
Patients with lumbar disc herniation
TECAR THERAPY
TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions
sham TECAR Therapy
Patients with lumbar disc herniation
TECAR Therapy
TECAR therapy is a new and effective treatment modality.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TECAR THERAPY
TECAR therapy applied by a technician for 20 minutes per session, three days per week, for a total of six sessions
TECAR Therapy
TECAR therapy is a new and effective treatment modality.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Having a diagnosis of lumbar disc herniation (bulging, protruded, or extruded)
Being able to comply with the exercise program
Willingness to participate in the study Being between 20 and 60 years of age
Exclusion Criteria
Having a known and/or newly diagnosed malignancy
Presence of cardiac implants such as a pacemaker
Having inflammatory low back pain
Having absolute spinal stenosis (anteroposterior diameter of the spinal canal \< 10 mm and anteroposterior diameter of the lateral recess \< 3 mm)
History of surgery due to lumbar disc herniation, lumbar spinal stenosis, vertebral fracture, or similar conditions
Presence of lumbar spondylolisthesis
Patients with sequestered disc herniation
Patients with polyneuropathy
Patients with central pain following stroke
Patients with neurological deficits
Having a diagnosed neurodegenerative disease
Having a systemic musculoskeletal disease
Patients with acute deep vein thrombosis
Pregnancy
Presence of infection at the skin surface where treatment will be applied
Unexplained weight loss
Bladder and/or bowel incontinence
Having received physical therapy modalities or injections for low back pain within the last 1 month
Having cognitive impairment
Refusal to participate in the study
\-
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cemre Saymaz
DOCTOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Bilkent City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
ankara bilkent city hospital ankara bilkent city hospital
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TABED 1-24-833
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.